Miniaturized Protein Microarray with Internal Calibration as Point-of-Care Device for Diagnosis of Neonatal Sepsis

Neonatal sepsis is still a leading cause of death among newborns. Therefore a protein-microarray for point-of-care testing that simultaneously quantifies the sepsis associated serum proteins IL-6, IL-8, IL-10, TNF alpha, S-100, PCT, E-Selectin, CRP and Neopterin has been developed. The chip works with only a 4 μL patient serum sample and hence minimizes excessive blood withdrawal from newborns. The 4 μL patient samples are diluted with 36 μL assay buffer and distributed to four slides for repetitive measurements. Streptavidin coated magnetic particles that act as distinct stirring detection components are added, not only to stir the sample, but also to detect antibody antigen binding events. We demonstrate that the test is complete within 2.5 h using a single step assay. S-100 conjugated to BSA is spotted in increasing concentrations to create an internal calibration. The presented low volume protein-chip fulfills the requirements of point-of-care testing for accurate and repeatable (CV < 14%) quantification of serum proteins for the diagnosis of neonatal sepsis.

[1]  Achim Wixforth,et al.  Enhancing results of microarray hybridizations through microagitation. , 2003, Journal of biomolecular techniques : JBT.

[2]  A. Turygin,et al.  Development of a biochip with an internal calibration curve for quantitating two forms of the prostate-specific antigen , 2007, Molecular Biology.

[3]  D. MacDougall,et al.  Guidelines for data acquisition and data quality evaluation in environmental chemistry , 1980 .

[4]  E. Bell,et al.  Evaluation of neutrophilic CD64, interleukin 10 and procalcitonin as diagnostic markers of early- and late-onset neonatal sepsis , 2010, Scandinavian journal of infectious diseases.

[5]  Patricia Johnson,et al.  Laboratory Evaluation of Neonatal Sepsis , 2010 .

[6]  Chien-Hsiung Tsai,et al.  Rapid magnetic microfluidic mixer utilizing AC electromagnetic field , 2009, Electrophoresis.

[7]  Ralf Junker,et al.  Point-of-care testing in hospitals and primary care. , 2010, Deutsches Arzteblatt international.

[8]  S. Weinstein,et al.  Neurological injury markers in children with septic shock* , 2008, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[9]  Bruce D Hammock,et al.  Multiplexed immunoassays for proteins using magnetic luminescent nanoparticles for internal calibration. , 2007, Analytical biochemistry.

[10]  Ursula Sauer,et al.  Protein microarray for the analysis of human melanoma biomarkers , 2009 .

[11]  B. Stoll,et al.  Neonatal sepsis: a major global public health challenge. , 2009, The Pediatric infectious disease journal.

[12]  A. Toegl,et al.  Increasing robustness and sensitivity of protein microarrays through microagitation and automation. , 2006, Analytica chimica acta.

[13]  Prashanta Dutta,et al.  A rapid magnetic particle driven micromixer , 2008 .

[14]  Joerg Schotter,et al.  Development of a magnetic lab-on-a-chip for point-of-care sepsis diagnosis , 2009 .

[15]  P. Auld,et al.  Diagnostic value of cytokines and C-reactive protein in the first 24 hours of neonatal sepsis. , 2003, American journal of perinatology.

[16]  Joshua E. Smith,et al.  Optimization of antibody-conjugated magnetic nanoparticles for target preconcentration and immunoassays. , 2011, Analytical biochemistry.

[17]  C. Lawlor,et al.  Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[18]  J. Schotter,et al.  Acceleration of incubation processes in DNA bio chips by magnetic particles , 2007 .

[19]  Ursula Sauer,et al.  Protein chip for the parallel quantification of high and low abundant biomarkers for sepsis. , 2011, Analytical biochemistry.

[20]  A. Armston The immunoassay handbook , 2014, Annals of clinical biochemistry.

[21]  Albert Kriegner,et al.  Identification of human pathogens isolated from blood using microarray hybridisation and signal pattern recognition , 2007, BMC Microbiology.

[22]  A. H. Parmelee Sepsis in the newborn. , 1947, American journal of diseases of children.

[23]  B. Pourakbari,et al.  Evaluation of procalcitonin and neopterin level in serum of patients with acute bacterial infection. , 2010, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[24]  Igor Goychuk,et al.  Optimal Design of Microarray Immunoassays to Compensate for Kinetic Limitations , 2006, Molecular & Cellular Proteomics.

[25]  T F Fok,et al.  Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants , 1997, Archives of disease in childhood. Fetal and neonatal edition.

[26]  M. Zaki,et al.  Evaluation of microbiologic and hematologic parameters and E-selectin as early predictors for outcome of neonatal sepsis. , 2009, Archives of pathology & laboratory medicine.

[27]  Leonel Sousa,et al.  Challenges and trends in the development of a magnetoresistive biochip portable platform , 2010 .